Phase I Study of KRN7000 in Patients With Solid Tumor Treated With a Weekly Intravenous Administration Schedule.
Withdrawn prior to enrolment
Phase of Trial: Phase I
Latest Information Update: 10 Jul 2012
At a glance
- Drugs Alpha galactosylceramide (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 10 Jul 2012 Status changed from active, no longer recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 17 Sep 2005 New trial record.